AMRX (STOCKS)
Amneal Pharmaceuticals, Inc. Class A Common Stock
$16.240000
+0.040000 (+0.25%)
Prev close: $16.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Chintu Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,180.93M
- Employees
- 8,100
- P/E (TTM)
- 43.43
- P/B (TTM)
- -113.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.05B |
| Benefits Costs and Expenses | $2.86B |
| Cost Of Revenue | $1.87B |
| Costs And Expenses | $2.86B |
| Gross Profit | $1.18B |
| Nonoperating Income/Loss | -$253.62M |
| Operating Expenses | $742.01M |
| Selling, General, and Administrative Expenses | $547.40M |
| Research and Development | $184.52M |
| Other Operating Expenses | $10.09M |
| Operating Income/Loss | $435.52M |
| Income/Loss From Continuing Operations After Tax | $181.32M |
| Income/Loss From Continuing Operations Before Tax | $181.90M |
| Income Tax Expense/Benefit | $584.00K |
| Net Income/Loss | $181.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $59.20M |
| Net Income/Loss Attributable To Parent | $122.12M |
| Net Income/Loss Available To Common Stockholders, Basic | $122.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.39 |
| Diluted Earnings Per Share | $0.38 |
| Basic Average Shares | 944,299,000 |
| Diluted Average Shares | 977,151,000 |
| Assets | $3.54B |
| Current Assets | $1.80B |
| Inventory | $641.62M |
| Other Current Assets | $1.16B |
| Noncurrent Assets | $1.74B |
| Fixed Assets | $444.61M |
| Intangible Assets | $534.87M |
| Other Non-current Assets | $762.84M |
| Liabilities | $3.50B |
| Current Liabilities | $728.05M |
| Noncurrent Liabilities | $2.77B |
| Long-term Debt | $2.57B |
| Other Non-current Liabilities | $200.47M |
| Equity | -$45.97M |
| Equity Attributable To Noncontrolling Interest | -$558.00K |
| Equity Attributable To Parent | -$45.41M |
| Temporary Equity | $85.91M |
| Liabilities And Equity | $3.54B |
| Net Cash Flow From Operating Activities | $305.84M |
| Net Cash Flow From Operating Activities, Continuing | $305.84M |
| Net Cash Flow From Investing Activities | -$116.18M |
| Net Cash Flow From Investing Activities, Continuing | -$116.18M |
| Net Cash Flow From Financing Activities | -$51.42M |
| Net Cash Flow From Financing Activities, Continuing | -$51.42M |
| Exchange Gains/Losses | -$2.23M |
| Net Cash Flow | $136.01M |
| Net Cash Flow, Continuing | $138.25M |
| Comprehensive Income/Loss | $95.71M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $95.71M |
| Other Comprehensive Income/Loss | -$85.61M |
| Other Comprehensive Income/Loss Attributable To Parent | -$26.41M |